Influence of hormones on osteogenic differentiation processes of mesenchymal stem cells

References

• Bernstein BE, Mikkelsen TS, Xie X et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125(2), 315–326 (2006).
   PubMed Web of Science ®Google Scholar
• Boyer LA, Plath K, Zeitlinger J et al. Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature 441(7091), 349–353 (2006).
   PubMed Web of Science ®Google Scholar
• Lee TI, Jenner RG, Boyer LA et al. Control of developmental regulators by polycomb in human embryonic stem cells. Cell 125(2), 301–313 (2006).
   PubMed Web of Science ®Google Scholar
• D’Ippolito G, Diabira S, Howard GA, Roos BA, Schiller PC. Low oxygen tension inhibits osteogenic differentiation and enhances stemness of human MIAMI cells. Bone 39(3), 513–522 (2006).
   PubMed Web of Science ®Google Scholar
• Schipani E. Hypoxia and HIF-1α in chondrogenesis. Ann. NY Acad. Sci. 1068, 66–73 (2006).
   PubMed Web of Science ®Google Scholar
• Hirao M, Tamai N, Tsumaki N, Yoshikawa H, Myoui A. Oxygen tension regulates chondrocyte differentiation and function during endochondral ossification. J. Biol. Chem. 281(41), 31079–31092 (2006).
   PubMed Web of Science ®Google Scholar
• Forriol F, Shapiro F. Bone development: interaction of molecular components and biophysical forces. Clin. Orthop. Relat. Res. (432), 14–33 (2005).
   Google Scholar
• Caplan AI. Review: mesenchymal stem cells: cell-based reconstructive therapy in orthopedics. Tissue Eng. 11(7–8), 1198–1211 (2005).
   PubMedGoogle Scholar
• Bianco P, Riminucci M, Gronthos S, Robey PG. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 19(3), 180–192 (2001).
   PubMed Web of Science ®Google Scholar
• Ohlstein B, Kai T, Decotto E, Spradling A. The stem cell niche: theme and variations. Curr. Opin. Cell Biol. 16(6), 693–699 (2004).
   PubMed Web of Science ®Google Scholar
• Fuchs E, Tumbar T, Guasch G. Socializing with the neighbors: stem cells and their niche. Cell 116(6), 769–778 (2004).
   PubMed Web of Science ®Google Scholar
• Calvi LM, Adams GB, Weibrecht KW et al. Osteoblastic cells regulate the hematopoietic stem cell niche. Nature 425(6960), 841–846 (2003).
   PubMed Web of Science ®Google Scholar
• Kuznetsov SA, Riminucci M, Ziran N et al. The interplay of osteogenesis and hematopoiesis: expression of a constitutively active PTH/PTHrP receptor in osteogenic cells perturbs the establishment of hematopoiesis in bone and of skeletal stem cells in the bone marrow. J. Cell Biol. 167(6), 1113–1122 (2004).
   PubMed Web of Science ®Google Scholar
• Calvi LM. Osteoblastic activation in the hematopoietic stem cell niche. Ann. NY Acad. Sci. 1068, 477–88 (2006).
   PubMed Web of Science ®Google Scholar
• Yin T, Li L. The stem cell niches in bone. J. Clin. Invest. 116(5), 1195–1201 (2006).
   PubMed Web of Science ®Google Scholar
• Abuljadayel IS. Induction of stem cell-like plasticity in mononuclear cells derived from unmobilised adult human peripheral blood. Curr. Med. Res. Opin. 19(5), 355–375 (2003).
   PubMed Web of Science ®Google Scholar
• Brockes JP, Kumar A. Plasticity and reprogramming of differentiated cells in amphibian regeneration. Nat. Rev. Mol. Cell Biol. 3(8), 566–574 (2002).
   PubMed Web of Science ®Google Scholar
• Grafi G. How cells dedifferentiate: a lesson from plants. Dev. Biol. 268(1), 1–6 (2004).
   PubMed Web of Science ®Google Scholar
• Grafi G, Avivi Y. Stem cells: a lesson from dedifferentiation. Trends Biotechnol. 22(8), 388–389 (2004).
   PubMed Web of Science ®Google Scholar
• Orkin SH, Zon LI. Hematopoiesis and stem cells: plasticity versus developmental heterogeneity. Nat. Immunol. 3(4), 323–328 (2002).
   PubMed Web of Science ®Google Scholar
• Tosh D, Slack JM. How cells change their phenotype. Nat. Rev. Mol. Cell Biol. 3(3), 187–194 (2002).
   PubMed Web of Science ®Google Scholar
• Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science 284(5411), 143–147 (1999).
   PubMed Web of Science ®Google Scholar
• Liechty KW, MacKenzie TC, Shaaban AF et al. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat. Med. 6(11), 1282–1286 (2000).
   PubMed Web of Science ®Google Scholar
• Tuan RS. Biology of developmental and regenerative skeletogenesis. Clin. Orthop. Relat. Res. (Suppl. 427), S105–S117 (2004).
   Google Scholar
• daSilvaMeirelles L, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J. Cell Sci. 119(Pt 11), 2204–2213 (2006).
   PubMed Web of Science ®Google Scholar
• Song L, Young NJ, Webb NE, Tuan RS. Origin and characterization of multipotential mesenchymal stem cells derived from adult human trabecular bone. Stem Cells Dev. 14(6), 712–721 (2005).
   PubMed Web of Science ®Google Scholar
• Djouad F, Bony C, Haupl T et al. Transcriptional profiles discriminate bone marrow-derived and synovium-derived mesenchymal stem cells. Arthritis Res. Ther. 7(6), R1304–R1315 (2005).
   PubMed Web of Science ®Google Scholar
• Dicker A, Le Blanc K, Astrom G L et al. Functional studies of mesenchymal stem cells derived from adult human adipose tissue. Exp. Cell Res. 308(2), 283–290 (2005).
   PubMed Web of Science ®Google Scholar
• Timper K, Seboek D, Eberhardt M et al. Human adipose tissue-derived mesenchymal stem cells differentiate into insulin, somatostatin, and glucagon expressing cells. Biochem. Biophys. Res. Commun. 341(4), 1135–1140 (2006).
   PubMed Web of Science ®Google Scholar
• Sacchetti B, Funari A, Di Cesare S et al. Direct identification, prospective isolation, and phenotype of in vivo self-renewing, multipotent skeletal stem cells. Calcif. Tissue Int. 78(S1), OC006 (2006).
   Google Scholar
• Udani VM. The continuum of stem cell transdifferentiation: possibility of hematopoietic stem cell plasticity with concurrent CD45 expression. Stem Cells Dev. 15(1), 1–3 (2006).
   PubMed Web of Science ®Google Scholar
• Cool SM, Grunert M, Jackson R, Li H, Nurcombe V, Waters MJ. Role of growth hormone receptor signaling in osteogenesis from murine bone marrow progenitor cells. Biochem. Biophys. Res. Commun. 338(2), 1048–1058 (2005).
   PubMed Web of Science ®Google Scholar
• Hong L, Colpan A, Peptan IA. Modulations of 17-β estradiol on osteogenic and adipogenic differentiations of human mesenchymal stem cells. Tissue Eng. (2006) (Epub ahead of print).
   Google Scholar
• Wang Q, Yu JH, Zhai HH et al. Temporal expression of estrogen receptor α in rat bone marrow mesenchymal stem cells. Biochem. Biophys. Res. Commun. 347(1), 117–123 (2006).
   PubMed Web of Science ®Google Scholar
• Song LH, Pan W, Yu YH, Quarles LD, Zhou HH, Xiao ZS. Resveratrol prevents CsA inhibition of proliferation and osteoblastic differentiation of mouse bone marrow-derived mesenchymal stem cells through an ER/NO/cGMP pathway. Toxicol. In vitro 20(6), 915–922 (2006).
   PubMed Web of Science ®Google Scholar
• Silvestrini G, Ballanti P, Patacchioli FR et al. Evaluation of apoptosis and the glucocorticoid receptor in the cartilage growth plate and metaphyseal bone cells of rats after high-dose treatment with corticosterone. Bone 26(1), 33–42 (2000).
   PubMed Web of Science ®Google Scholar
• Derfoul A, Perkins GL, Hall DJ, Tuan RS. Glucocorticoids promote chondrogenic differentiation of adult human mesenchymal stem cells by enhancing expression of cartilage extracellular matrix genes. Stem Cells 24(6), 1487–1495 (2006).
   PubMed Web of Science ®Google Scholar
• Ochi K, Derfoul A, Tuan RS. A predominantly articular cartilage-associated gene, SCRG1, is induced by glucocorticoid and stimulates chondrogenesis in vitro. Osteoarthritis Cartilage 14(1), 30–38 (2006).
   PubMed Web of Science ®Google Scholar
• Wilson EM, Rotwein P. Control of MyoD function during initiation of muscle differentiation by an autocrine signaling pathway activated by insulin-like growth factor-II. J. Biol. Chem. 281(40), 29962–29971 (2006).
   PubMed Web of Science ®Google Scholar
• Hess R, Pino AM, Rios S, Fernandez M, Rodriguez JP. High affinity leptin receptors are present in human mesenchymal stem cells (MSCs) derived from control and osteoporotic donors. J. Cell. Biochem. 94(1), 50–57 (2005).
   PubMed Web of Science ®Google Scholar
• Siddiqi A, Parsons MP, Lewis JL, Monson JP, Williams GR, Burrin JM. TR expression and function in human bone marrow stromal and osteoblast-like cells. J. Clin. Endocrinol. Metab. 87(2), 906–914 (2002).
   PubMed Web of Science ®Google Scholar
• Gruber R, Czerwenka K, Wolf F, Ho GM, Willheim M, Peterlik M. Expression of the vitamin D receptor, of estrogen and thyroid hormone receptor α- and β-isoforms, and of the androgen receptor in cultures of native mouse bone marrow and of stromal/osteoblastic cells. Bone 24(5), 465–473 (1999).
   PubMed Web of Science ®Google Scholar
• Chang CY, Hsuuw YD, Huang FJ et al. Androgenic and antiandrogenic effects and expression of androgen receptor in mouse embryonic stem cells. Fertil. Steril. 85(Suppl. 1), S1195–1203 (2006).
   PubMed Web of Science ®Google Scholar
• Tada S, Era T, Furusawa C et al. Characterization of mesendoderm: a diverging point of the definitive endoderm and mesoderm in embryonic stem cell differentiation culture. Development 132(19), 4363–4374 (2005).
   PubMed Web of Science ®Google Scholar
• Beattie GM, Lopez AD, Bucay N et al. Activin A maintains pluripotency of human embryonic stem cells in the absence of feeder layers. Stem Cells 23(4), 489–495 (2005).
   PubMed Web of Science ®Google Scholar
• Timmer J, Chesnutt C, Niswander L. The activin signaling pathway promotes differentiation of dI3 interneurons in the spinal neural tube. Dev. Biol. 285(1), 1–10 (2005).
   PubMed Web of Science ®Google Scholar
• Han HJ, Lee YJ. Insulin stimulates Ca2+ uptake via PKC, cAMP, and p38 MAPK in mouse embryonic stem cells. Life Sci. 76(25), 2903–2919 (2005).
   PubMed Web of Science ®Google Scholar
• Koussoulakos S. Vertebrate limb development: from Harrison’s limb disk transplantations to targeted disruption of Hox genes. Anat. Embryol. (Berl.) 209(2), 93–105 (2004).
   PubMedGoogle Scholar
• Dobnig H, Turner RT. Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells. Endocrinology 136(8), 3632–3638 (1995).
   PubMed Web of Science ®Google Scholar
• Neer RM, Arnaud CD, Zanchetta JR et al. Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N. Engl. J. Med. 344(19), 1434–1441 (2001).
   PubMed Web of Science ®Google Scholar
• Kneissel M, Boyde A, Gasser JA. Bone tissue and its mineralization in aged estrogen-depleted rats after long-term intermittent treatment with parathyroid hormone (PTH) analog SDZ PTS 893 or human PTH(1–34). Bone 28(3), 237–250 (2001).
   PubMed Web of Science ®Google Scholar
• Girotra M, Rubin MR, Bilezikian JP. The use of parathyroid hormone in the treatment of osteoporosis. Rev. Endocr. Metab. Disord. (2006) (Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Han M, Yang X, Taylor G, Burdsal CA, Anderson RA, Muneoka K. Limb regeneration in higher vertebrates: developing a roadmap. Anat. Rec. B New Anat. 287(1), 14–24 (2005).
   PubMedGoogle Scholar
• Ornitz DM, Marie PJ. FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev. 16(12), 1446–1465 (2002).
   PubMed Web of Science ®Google Scholar
• Nilsson O, Marino R, De Luca F, Phillip M, Baron J. Endocrine regulation of the growth plate. Horm. Res. 64(4), 157–165 (2005).
   PubMedGoogle Scholar
• Gafni RI, Weise M, Robrecht DT et al. Catch-up growth is associated with delayed senescence of the growth plate in rabbits. Pediatr. Res. 50(5), 618–623 (2001).
   PubMed Web of Science ®Google Scholar
• Weise M, De-Levi S, Barnes KM, Gafni RI, Abad V, Baron J. Effects of estrogen on growth plate senescence and epiphyseal fusion. Proc. Natl Acad. Sci. USA 98(12), 6871–6876 (2001).
   PubMed Web of Science ®Google Scholar
• Kronenberg HM. Developmental regulation of the growth plate. Nature 423(6937), 332–336 (2003).
   PubMed Web of Science ®Google Scholar
• Provot S, Schipani E. Molecular mechanisms of endochondral bone development. Biochem. Biophys. Res. Commun. 328(3), 658–665 (2005).
   PubMed Web of Science ®Google Scholar
• Dardenne O, Prud’homme J, Arabian A, Glorieux FH, St-Arnaud R. targeted inactivation of the 25-hydroxyvitamin D3–1α-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets. Endocrinology 142(7), 3135–3141 (2001).
   PubMed Web of Science ®Google Scholar
• Amling M, Priemel M, Holzmann T et al. Rescue of the skeletal phenotype of vitamin D receptor-ablated mice in the setting of normal mineral ion homeostasis: formal histomorphometric and biomechanical analyses. Endocrinology 140(11), 4982–4987 (1999).
   PubMed Web of Science ®Google Scholar
• Schwartz Z, Ehland H, Sylvia VL et al. 1α,25-dihydroxyvitamin D(3) and 24R,25-dihydroxyvitamin D(3) modulate growth plate chondrocyte physiology via protein kinase C-dependent phosphorylation of extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase. Endocrinology 143(7), 2775–2786 (2002).
   PubMed Web of Science ®Google Scholar
• Schwartz Z, Pedrozo HA, Sylvia VL, Gomez R, Dean DD, Boyan BD. 1α,25-(OH)2D3 regulates 25-hydroxyvitamin D3 24R-hydroxylase activity in growth zone costochondral growth plate chondrocytes via protein kinase C. Calcif. Tissue Int. 69(6), 365–372 (2001).
   PubMed Web of Science ®Google Scholar
• Daughaday WH, Hall K, Raben MS, Salmon WD Jr, van den Brande JL, van Wyk JJ. Somatomedin: proposed designation for sulphation factor. Nature 235(5333), 107 (1972).
   PubMed Web of Science ®Google Scholar
• Yakar S, Sun H, Zhao H et al. Metabolic effects of IGF-I deficiency: lessons from mouse models. Pediatr. Endocrinol. Rev. 3(1), 11–9 (2005).
   PubMedGoogle Scholar
• Schlechter NL, Russell SM, Spencer EM, Nicoll CS. Evidence suggesting that the direct growth-promoting effect of growth hormone on cartilage in vivo is mediated by local production of somatomedin. Proc. Natl Acad. Sci. USA 83(20), 7932–7934 (1986).
   PubMed Web of Science ®Google Scholar
• Ohlsson C, Nilsson A, Isaksson O, Lindahl A. Growth hormone induces multiplication of the slowly cycling germinal cells of the rat tibial growth plate. Proc. Natl Acad. Sci. USA 89(20), 9826–9830 (1992).
   PubMed Web of Science ®Google Scholar
• Isaksson OG, Lindahl A, Nilsson A, Isgaard J. Mechanism of the stimulatory effect of growth hormone on longitudinal bone growth. Endocr. Rev. 8(4), 426–438 (1987).
   PubMed Web of Science ®Google Scholar
• Schoenau E. Bone mass increase in puberty: what makes it happen? Horm. Res. 65(Suppl. 2), S2–10 (2006).
   PubMedGoogle Scholar
• Blanchard O, Tsagris L, Rappaport R, Duval-Beaupere G, Corvol M. Age-dependent responsiveness of rabbit and human cartilage cells to sex steroids in vitro. J. Steroid Biochem. Mol. Biol. 40(4–6), 711–716 (1991).
   PubMed Web of Science ®Google Scholar
• Gunther DF, Calikoglu AS, Underwood LE. The effects of the estrogen receptor blocker, Faslodex (ICI 182,780), on estrogen-accelerated bone maturation in mice. Pediatr. Res. 46(3), 269–273 (1999).
   PubMed Web of Science ®Google Scholar
• Nilsson O, Chrysis D, Pajulo O et al. Localization of estrogen receptors-α and -β and androgen receptor in the human growth plate at different pubertal stages. J. Endocrinol. 177(2), 319–326 (2003).
   PubMed Web of Science ®Google Scholar
• Walenkamp MJ, Wit JM. Genetic disorders in the growth hormone – insulin-like growth factor-I axis. Horm. Res. 66(5), 221–230 (2006).
   PubMedGoogle Scholar
• Venken K, Schuit F, Van Lommel L et al. Growth without growth hormone receptor: estradiol is a major growth hormone-independent regulator of hepatic IGF-I synthesis. J. Bone Miner. Res. 20(12), 2138–2149 (2005).
   PubMed Web of Science ®Google Scholar
• Oz OK, Millsaps R, Welch R, Birch J, Zerwekh JE. Expression of aromatase in the human growth plate. J. Mol. Endocrinol. 27(2), 249–253 (2001).
   PubMed Web of Science ®Google Scholar
• Keenan BS, Richards GE, Ponder SW, Dallas JS, Nagamani M, Smith ER. Androgen-stimulated pubertal growth: the effects of testosterone and dihydrotestosterone on growth hormone and insulin-like growth factor-I in the treatment of short stature and delayed puberty. J. Clin. Endocrinol. Metab. 76(4), 996–1001 (1993).
   PubMed Web of Science ®Google Scholar
• Chrysis D, Ritzen EM, Savendahl L. Growth retardation induced by dexamethasone is associated with increased apoptosis of the growth plate chondrocytes. J. Endocrinol. 176(3), 331–337 (2003).
   PubMed Web of Science ®Google Scholar
• Smink JJ, Koster JG, Gresnigt MG, Rooman R, Koedam JA, Van Buul-Offers SC. IGF and IGF-binding protein expression in the growth plate of normal, dexamethasone-treated and human IGF-II transgenic mice. J. Endocrinol. 175(1), 143–153 (2002).
   PubMed Web of Science ®Google Scholar
• Heinrichs C, Yanovski JA, Roth AH et al. Dexamethasone increases growth hormone receptor messenger ribonucleic acid levels in liver and growth plate. Endocrinology 135(3), 1113–1118 (1994).
   PubMed Web of Science ®Google Scholar
• Bassett JH, Williams GR. The molecular actions of thyroid hormone in bone. Trends Endocrinol. Metab. 14(8), 356–364 (2003).
   PubMed Web of Science ®Google Scholar
• Ballock R, Mita BC, Zhou X, Chen DH, Mink LM. Expression of thyroid hormone receptor isoforms in rat growth plate cartilage in vivo. J. Bone Miner. Res. 14(9), 1550–1556 (1999).
   PubMed Web of Science ®Google Scholar
• Takeda K, Sakurai A, DeGroot LJ, Refetoff S. Recessive inheritance of thyroid hormone resistance caused by complete deletion of the protein-coding region of the thyroid hormone receptor-β gene. J. Clin. Endocrinol. Metab. 74(1), 49–55 (1992).
   PubMed Web of Science ®Google Scholar
• Steppan CM, Crawford DT, Chidsey-Frink KL, Ke H, Swick AG. Leptin is a potent stimulator of bone growth in ob/ob mice. Regul. Pept. 92(1–3), 73–78 (2000).
   PubMed Web of Science ®Google Scholar
• Maor G, Rochwerger M, Segev Y, Phillip M. Leptin acts as a growth factor on the chondrocytes of skeletal growth centers. J. Bone Miner. Res. 17(6), 1034–1043 (2002).
   PubMed Web of Science ®Google Scholar
• Sanyal A, Riggs BL, Spelsberg TC, Khosla S. Bone marrow stromal cells express two distinct splice variants of ER-α that are regulated by estrogen. J. Cell. Biochem. 94(1), 88–97 (2005).
   PubMed Web of Science ®Google Scholar
• Zhou S, Zilberman Y, Wassermann K, Bain SD, Sadovsky Y, Gazit D. Estrogen modulates estrogen receptor α and β expression, osteogenic activity, and apoptosis in mesenchymal stem cells (MSCs) of osteoporotic mice. J. Cell Biochem. Suppl. Suppl. 36, 144–155 (2001).
   Google Scholar
• Zhou S, Turgeman G, Harris SE et al. Estrogens activate bone morphogenetic protein-2 gene transcription in mouse mesenchymal stem cells. Mol. Endocrinol. 17(1), 56–66 (2003).
   PubMedGoogle Scholar
• Okazaki R, Inoue D, Shibata M et al. Estrogen promotes early osteoblast differentiation and inhibits adipocyte differentiation in mouse bone marrow stromal cell lines that express estrogen receptor (ER) α or β. Endocrinology 143(6), 2349–2356 (2002).
   PubMed Web of Science ®Google Scholar
• Pan W, Quarles LD, Song LH et al. Genistein stimulates the osteoblastic differentiation via NO/cGMP in bone marrow culture. J. Cell. Biochem. 94(2), 307–316 (2005).
   PubMed Web of Science ®Google Scholar
• Dang ZC, Audinot V, Papapoulos SE, Boutin JA, Lowik CW. Peroxisome proliferator-activated receptor γ (PPARγ ) as a molecular target for the soy phytoestrogen genistein. J. Biol. Chem. 278(2), 962–967 (2003).
   PubMed Web of Science ®Google Scholar
• Rickard DJ, Hofbauer LC, Bonde SK, Gori F, Spelsberg TC, Riggs BL. Bone morphogenetic protein-6 production in human osteoblastic cell lines. Selective regulation by estrogen. J. Clin. Invest. 101(2), 413–422 (1998).
   PubMed Web of Science ®Google Scholar
• Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Spelsberg TC, Riggs BL. Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells. Endocrinology 140(9), 4367–4370 (1999).
   PubMed Web of Science ®Google Scholar
• Spelsberg TC, Subramaniam M, Riggs BL, Khosla S. The actions and interactions of sex steroids and growth factors/cytokines on the skeleton. Mol. Endocrinol. 13(6), 819–828 (1999).
   PubMed Web of Science ®Google Scholar
• Raisz LG. Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J. Clin. Invest. 115(12), 3318–3325 (2005).
   PubMed Web of Science ®Google Scholar
• Vunjak-Novakovic G, Meinel L, Altman G, Kaplan D. Bioreactor cultivation of osteochondral grafts. Orthod. Craniofac. Res. 8(3), 209–218 (2005).
   PubMedGoogle Scholar
• Huang CY, Hagar KL, Frost LE, Sun Y, Cheung HS. Effects of cyclic compressive loading on chondrogenesis of rabbit bone-marrow derived mesenchymal stem cells. Stem Cells 22(3), 313–323 (2004).
   PubMed Web of Science ®Google Scholar
• Riddle RC, Taylor AF, Genetos DC, Donahue HJ. MAP kinase and calcium signaling mediate fluid flow-induced human mesenchymal stem cell proliferation. Am. J. Physiol. Cell Physiol. 290(3), C776–C784 (2006).
   Google Scholar
• Bakker AD, Klein-Nulend J, Tanck E, Albers GH, Lips P, Burger EH. Additive effects of estrogen and mechanical stress on nitric oxide and prostaglandin E2 production by bone cells from osteoporotic donors. Osteoporos Int. 16(8), 983–989 (2005).
   PubMed Web of Science ®Google Scholar
• Lima F, Vico L, Lafage-Proust MH, van der Saag P, Alexandre C, Thomas T. Interactions between estrogen and mechanical strain effects on U2OS human osteosarcoma cells are not influenced by estrogen receptor type. Bone 35(5), 1127–1135 (2004).
   PubMed Web of Science ®Google Scholar
• Jessop HL, Sjoberg M, Cheng MZ, Zaman G, Wheeler-Jones CP, Lanyon LE. Mechanical strain and estrogen activate estrogen receptor α in bone cells. J. Bone Miner. Res. 16(6), 1045–1055 (2001).
   PubMed Web of Science ®Google Scholar
• Jessop HL, Suswillo RF, Rawlinson SC et al. Osteoblast-like cells from estrogen receptor α knockout mice have deficient responses to mechanical strain. J. Bone Miner. Res. 19(6), 938–946 (2004).
   PubMed Web of Science ®Google Scholar
• Damien E, Price JS, Lanyon LE. Mechanical strain stimulates osteoblast proliferation through the estrogen receptor in males as well as females. J. Bone Miner. Res. 15(11), 2169–2177 (2000).
   PubMed Web of Science ®Google Scholar
• Lee K, Jessop H, Suswillo R, Zaman G, Lanyon L. Endocrinology: bone adaptation requires oestrogen receptor-α. Nature 424(6947), 389 (2003).
   PubMed Web of Science ®Google Scholar
• Fromigue O, Marie PJ, Lomri A. Differential effects of transforming growth factor β2, dexamethasone and 1,25-dihydroxyvitamin D on human bone marrow stromal cells. Cytokine 9(8), 613–623 (1997).
   PubMed Web of Science ®Google Scholar
• Rickard DJ, Kazhdan I, Leboy PS. Importance of 1,25-dihydroxyvitamin D3 and the nonadherent cells of marrow for osteoblast differentiation from rat marrow stromal cells. Bone 16(6), 671–678 (1995).
   PubMed Web of Science ®Google Scholar
• D’Ippolito G, Schiller PC, Perez-stable C, Balkan W, Roos BA, Howard GA. Cooperative actions of hepatocyte growth factor and 1,25-dihydroxyvitamin D3 in osteoblastic differentiation of human vertebral bone marrow stromal cells. Bone 31(2), 269–275 (2002).
   PubMed Web of Science ®Google Scholar
• Beresford JN. Osteogenic stem cells and the stromal system of bone and marrow. Clin. Orthop. Relat. Res. (240), 270–280 (1989).
   PubMed Web of Science ®Google Scholar
• Erben RG, Soegiarto DW, Weber K et al. Deletion of deoxyribonucleic acid binding domain of the vitamin D receptor abrogates genomic and nongenomic functions of vitamin D. Mol. Endocrinol. 16(7), 1524–1537 (2002).
   PubMedGoogle Scholar
• St-Arnaud R, Dardenne O, Prud’homme J, Hacking SA, Glorieux FH. Conventional and tissue-specific inactivation of the 25-hydroxyvitamin D-1α-hydroxylase (CYP27B1). J. Cell. Biochem. 88(2), 245–251 (2003).
   PubMed Web of Science ®Google Scholar
• Panda DK, Miao D, Bolivar I et al. Inactivation of the 25-hydroxyvitamin D 1α-hydroxylase and vitamin D receptor demonstrates independent and interdependent effects of calcium and vitamin D on skeletal and mineral homeostasis. J. Biol. Chem. 279(16), 16754–16766 (2004).
   PubMed Web of Science ®Google Scholar
• Ebert R, Schutze N, Adamski J, Jakob F. Vitamin D signaling is modulated on multiple levels in health and disease. Mol. Cell. Endocrinol. 248(1–2), 149–159 (2006).
   PubMed Web of Science ®Google Scholar
• Riminucci M, Collins MT, Fedarko NS et al. FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J. Clin. Invest. 112(5), 683–692 (2003).
   PubMed Web of Science ®Google Scholar
• Shimada T, Kakitani M, Yamazaki Y et al. Targeted ablation of FGF23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J. Clin. Invest. 113(4), 561–568 (2004).
   PubMed Web of Science ®Google Scholar
• Razzaque MS, Sitara D, Taguchi T, St-Arnaud R, Lanske B. Premature aging-like phenotype in fibroblast growth factor 23 null mice is a vitamin D-mediated process. FASEB J. 20(6), 720–722 (2006).
   PubMed Web of Science ®Google Scholar
• Yu X, White KE. FGF23 and disorders of phosphate homeostasis. Cytokine Growth Factor Rev. 16(2), 221–232 (2005).
   PubMed Web of Science ®Google Scholar
• Eswarakumar VP, Lax I, Schlessinger J. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev. 16(2), 139–149 (2005).
   PubMed Web of Science ®Google Scholar
• Carter PH, Schipani E. The roles of parathyroid hormone and calcitonin in bone remodeling: prospects for novel therapeutics. Endocr. Metab. Immune Disord. Drug Targets 6(1), 59–76 (2006).
   PubMedGoogle Scholar
• van der Horst G, Farih-Sips H, Lowik CW, Karperien M. Multiple mechanisms are involved in inhibition of osteoblast differentiation by PTHrP and PTH in KS483 Cells. J. Bone Miner. Res. 20(12), 2233–2244 (2005).
   PubMed Web of Science ®Google Scholar
• Zerega B, Cermelli S, Bianco P, Cancedda R, Cancedda FD. Parathyroid hormone [PTH(1–34)] and parathyroid hormone-related protein [PTHrP(1–34)] promote reversion of hypertrophic chondrocytes to a prehypertrophic proliferating phenotype and prevent terminal differentiation of osteoblast-like cells. J. Bone Miner. Res. 14(8), 1281–1289 (1999).
   PubMed Web of Science ®Google Scholar
• Martinez ME, Garcia-Ocana A, Sanchez M et al. C-terminal parathyroid hormone-related protein inhibits proliferation and differentiation of human osteoblast-like cells. J. Bone Miner. Res. 12(5), 778–785 (1997).
   PubMed Web of Science ®Google Scholar
• Ishizuya T, Yokose S, Hori M et al. Parathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteoblastic cells. J. Clin. Invest. 99(12), 2961–2970 (1997).
   PubMed Web of Science ®Google Scholar
• Isogai Y, Akatsu T, Ishizuya T et al. Parathyroid hormone regulates osteoblast differentiation positively or negatively depending on the differentiation stages. J. Bone Miner. Res. 11(10), 1384–1393 (1996).
   PubMed Web of Science ®Google Scholar
• Ryder KD, Duncan RL. Parathyroid hormone modulates the response of osteoblast-like cells to mechanical stimulation. Calcif. Tissue Int. 67(3), 241–246 (2000).
   PubMed Web of Science ®Google Scholar
• Miyauchi A, Notoya K, Mikuni-Takagaki Y et al. Parathyroid hormone-activated volume-sensitive calcium influx pathways in mechanically loaded osteocytes. J. Biol. Chem. 275(5), 3335–3342 (2000).
   PubMed Web of Science ®Google Scholar
• Chow JW, Fox S, Jagger CJ, Chambers TJ. Role for parathyroid hormone in mechanical responsiveness of rat bone. Am. J. Physiol. 274(1 Pt 1), E146–E154 (1998).
   Google Scholar
• Sekiya H, Mikuni-Takagaki Y, Kondoh T, Seto K. Synergistic effect of PTH on the mechanical responses of human alveolar osteocytes. Biochem. Biophys. Res. Commun. 264(3), 719–723 (1999).
   PubMed Web of Science ®Google Scholar
• Ma Y, Jee WS, Yuan Z, Wei W, Chen H, Pun S et al. Parathyroid hormone and mechanical usage have a synergistic effect in rat tibial diaphyseal cortical bone. J. Bone Miner. Res. 14(3), 439–448 (1999).
   PubMed Web of Science ®Google Scholar
• Li J, Duncan RL, Burr DB, Gattone VH, Turner CH. Parathyroid hormone enhances mechanically induced bone formation, possibly involving L-type voltage-sensitive calcium channels. Endocrinology 144(4), 1226–1233 (2003).
   PubMed Web of Science ®Google Scholar
• Chen W, Liu J, Diao W, Tang J, Ji J. Bone loss induced by ovariectomy in rats is prevented by gene transfer of parathyroid hormone or an Arg–Gly–Asp-containing peptide. Biotechnol. Lett. 27(1), 41–48 (2005).
   PubMed Web of Science ®Google Scholar
• Murphy E, Williams GR. The thyroid and the skeleton. Clin. Endocrinol. (Oxf.) 61(3), 285–298 (2004).
   PubMed Web of Science ®Google Scholar
• Harvey CB, O’Shea PJ, Scott AJ et al. Molecular mechanisms of thyroid hormone effects on bone growth and function. Mol. Genet. Metab. 75(1), 17–30 (2002).
   PubMed Web of Science ®Google Scholar
• O’Shea PJ, Harvey CB, Suzuki H et al. A thyrotoxic skeletal phenotype of advanced bone formation in mice with resistance to thyroid hormone. Mol. Endocrinol. 17(7), 1410–1424 (2003).
   PubMedGoogle Scholar
• Abe E, Marians RC, Yu W et al. TSH is a negative regulator of skeletal remodeling. Cell 115(2), 151–162 (2003).
   PubMed Web of Science ®Google Scholar
• Ueland T. GH/IGF-I and bone resorption in vivo and in vitro. Eur. J. Endocrinol. 152(3), 327–332 (2005).
   PubMed Web of Science ®Google Scholar
• Koch H, Jadlowiec JA, Campbell PG. Insulin-like growth factor-I induces early osteoblast gene expression in human mesenchymal stem cells. Stem Cells Dev. 14(6), 621–631 (2005).
   PubMed Web of Science ®Google Scholar
• Celil AB, Campbell PG. BMP-2 and insulin-like growth factor-I mediate Osterix (Osx) expression in human mesenchymal stem cells via the MAPK and protein kinase D signaling pathways. J. Biol. Chem. 280(36), 31353–31359 (2005).
   PubMed Web of Science ®Google Scholar
• Lange M, Qvortrup K, Svendsen OL et al. Abnormal bone collagen morphology and decreased bone strength in growth hormone-deficient rats. Bone 35(1), 178–185 (2004).
   PubMed Web of Science ®Google Scholar
• Christoforidis A, Maniadaki I, Stanhope R. Growth hormone/insulin-like growth factor-1 axis during puberty. Pediatr. Endocrinol. Rev. 3(1), 5–10 (2005).
   PubMedGoogle Scholar
• Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature 395(6704), 763–770 (1998).
   PubMed Web of Science ®Google Scholar
• Karsenty G. Leptin controls bone formation through a hypothalamic relay. Recent Prog. Horm. Res. 56, 401–415 (2001).
   PubMedGoogle Scholar
• Cohen MM Jr. Role of leptin in regulating appetite, neuroendocrine function, and bone remodeling. Am. J. Med. Genet. A. 140(5), 515–524 (2006).
   PubMed Web of Science ®Google Scholar
• Thomas T, Gori F, Khosla S, Jensen MD, Burguera B, Riggs BL. Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology 140(4), 1630–1638 (1999).
   PubMed Web of Science ®Google Scholar
• Lamghari M, Tavares L, Camboa N, Barbosa MA. Leptin effect on RANKL and OPG expression in MC3T3-E1 osteoblasts. J. Cell. Biochem. 98(5), 1123–1129 (2006).
   PubMed Web of Science ®Google Scholar
• Thomas T, Burguera B. Is leptin the link between fat and bone mass? J. Bone Miner. Res. 17(9), 1563–1569 (2002).
   PubMed Web of Science ®Google Scholar
• Gordeladze JO, Reseland JE. A unified model for the action of leptin on bone turnover. J. Cell. Biochem. 88(4), 706–712 (2003).
   PubMed Web of Science ®Google Scholar
• Smink JJ, Buchholz IM, Hamers N et al. Short-term glucocorticoid treatment of piglets causes changes in growth plate morphology and angiogenesis. Osteoarthritis Cartilage 11(12), 864–871 (2003).
   PubMed Web of Science ®Google Scholar
• Dimitriou R, Tsiridis E, Giannoudis PV. Current concepts of molecular aspects of bone healing. Injury 36(12), 1392–1404 (2005).
   PubMed Web of Science ®Google Scholar
• Einhorn TA. The science of fracture healing. J. Orthop. Trauma 19(Suppl. 10), S4–S6 (2005).
   PubMed Web of Science ®Google Scholar
• Iu MF, Kaji H, Naito J, Sowa H, Sugimoto T, Chihara K. Low-dose parathyroid hormone and estrogen reverse alkaline phosphatase activity suppressed by dexamethasone in mouse osteoblastic cells. J. Bone Miner. Metab. 23(6), 450–455 (2005).
   PubMed Web of Science ®Google Scholar
• vonStechow D, Zurakowski D, Pettit AR et al. Differential transcriptional effects of PTH and estrogen during anabolic bone formation. J. Cell. Biochem. 93(3), 476–490 (2004).
   PubMed Web of Science ®Google Scholar
• Rattanakul C, Lenbury Y, Krishnamara N, Wollkind DJ. Modeling of bone formation and resorption mediated by parathyroid hormone: response to estrogen/PTH therapy. Biosystems 70(1), 55–72 (2003).
   PubMed Web of Science ®Google Scholar
• Ohnaka K, Tanabe M, Kawate H, Nawata H, Takayanagi R. Glucocorticoid suppresses the canonical Wnt signal in cultured human osteoblasts. Biochem. Biophys. Res. Commun. 329(1), 177–181 (2005).
   PubMed Web of Science ®Google Scholar
• Ohnaka K, Taniguchi H, Kawate H, Nawata H, Takayanagi R. Glucocorticoid enhances the expression of dickkopf-1 in human osteoblasts: novel mechanism of glucocorticoid-induced osteoporosis. Biochem. Biophys. Res. Commun. 318(1), 259–264 (2004).
   PubMed Web of Science ®Google Scholar
• Justesen J, Stenderup K, Ebbesen EN, Mosekilde L, Steiniche T, Kassem M. Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis. Biogerontology 2(3), 165–171 (2001).
   PubMed Web of Science ®Google Scholar
• Cohen-Solal ME, Shih MS, Lundy MW, Parfitt AM. A new method for measuring cancellous bone erosion depth: application to the cellular mechanisms of bone loss in postmenopausal osteoporosis. J. Bone Miner. Res. 6(12), 1331–1338 (1991).
   PubMed Web of Science ®Google Scholar
• Carano RA, Filvaroff EH. Angiogenesis and bone repair. Drug Discov. Today 8(21), 980–989 (2003).
   PubMed Web of Science ®Google Scholar
• Lienau J, Schell H, Epari DR et al. CYR61 (CCN1) protein expression during fracture healing in an ovine tibial model and its relation to the mechanical fixation stability. J. Orthop. Res. 24(2), 254–262 (2006).
   PubMed Web of Science ®Google Scholar
• Gerstenfeld LC, Cullinane DM, Barnes GL, Graves DT, Einhorn TA. Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation. J. Cell. Biochem. 88(5), 873–884 (2003).
   PubMed Web of Science ®Google Scholar
• Enomoto H, Furuichi T, Zanma A et al. Runx2 deficiency in chondrocytes causes adipogenic changes in vitro. J. Cell Sci. 117(Pt 3), 417–425 (2004).
   PubMed Web of Science ®Google Scholar
• Khan E, Abu-Amer Y. Activation of peroxisome proliferator-activated receptor-γ inhibits differentiation of preosteoblasts. J. Lab. Clin. Med. 142(1), 29–34 (2003).
   PubMed Web of Science ®Google Scholar
• Dang ZC, van Bezooijen RL, Karperien M, Papapoulos SE, Lowik CW. Exposure of KS483 cells to estrogen enhances osteogenesis and inhibits adipogenesis. J. Bone Miner. Res. 17(3), 394–405 (2002).
   PubMed Web of Science ®Google Scholar
• Plant A, Samuels A, Perry MJ, Colley S, Gibson R, Tobias JH. Estrogen-induced osteogenesis in mice is associated with the appearance of Cbfa1-expressing bone marrow cells. J. Cell. Biochem. 84(2), 285–294 (2002).
   PubMed Web of Science ®Google Scholar
• Sottile V, Seuwen K, Kneissel M. Enhanced marrow adipogenesis and bone resorption in estrogen-deprived rats treated with the PPARγ agonist BRL49653 (rosiglitazone). Calcif. Tissue Int. 75(4), 329–337 (2004).
   PubMed Web of Science ®Google Scholar
• Schilling T, Nöth U, Klein-Hitpass L, Jakob F, Schütze N. Plasticity in adipogenesis and osteogenesis of human mesenchymal stem cells. Mol. Cell. Endocrinology (2006) (In Press).
   Google Scholar
• Song L, Tuan RS. Transdifferentiation potential of human mesenchymal stem cells derived from bone marrow. FASEB J. 18(9), 980–982 (2004).
   PubMed Web of Science ®Google Scholar
• Verfaillie CM. Adult stem cells: assessing the case for pluripotency. Trends Cell Biol. 12(11), 502–508 (2002).
   PubMed Web of Science ®Google Scholar
• Meunier P, Aaron J, Edouard C, Vignon G. Osteoporosis and the replacement of cell populations of the marrow by adipose tissue. A quantitative study of 84 iliac bone biopsies. Clin. Orthop. Relat. Res. 80, 147–154 (1971).
   PubMed Web of Science ®Google Scholar
• Burkhardt R, Kettner G, Bohm W et al. Changes in trabecular bone, hematopoiesis and bone marrow vessels in aplastic anemia, primary osteoporosis, and old age: a comparative histomorphometric study. Bone 8(3), 157–164 (1987).
   PubMed Web of Science ®Google Scholar
• Nuttall ME, Gimble JM. Is there a therapeutic opportunity to either prevent or treat osteopenic disorders by inhibiting marrow adipogenesis? Bone 27(2), 177–184 (2000).
   PubMed Web of Science ®Google Scholar
• Pei L, Tontonoz P. Fat’s loss is bone’s gain. J. Clin. Invest. 113(6), 805–806 (2004).
   PubMed Web of Science ®Google Scholar
• Beresford JN, Bennett JH, Devlin C, Leboy PS, Owen ME. Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures. J. Cell Sci. 102 (Pt 2), 341–351 (1992).
   PubMed Web of Science ®Google Scholar
• Ahdjoudj S, Fromigue O, Marie PJ. Plasticity and regulation of human bone marrow stromal osteoprogenitor cells: potential implication in the treatment of age-related bone loss. Histol. Histopathol. 19(1), 151–157 (2004).
   PubMed Web of Science ®Google Scholar
• D’Ippolito G, Schiller PC, Ricordi C, Roos BA, Howard GA. Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow. J. Bone Miner. Res. 14(7), 1115–1122 (1999).
   PubMed Web of Science ®Google Scholar
• Kajkenova O, Lecka-Czernik B, Gubrij I et al. Increased adipogenesis and myelopoiesis in the bone marrow of SAMP6, a murine model of defective osteoblastogenesis and low turnover osteopenia. J. Bone Miner. Res. 12(11), 1772–1779 (1997).
   PubMed Web of Science ®Google Scholar
• Justesen J, Stenderup K, Eriksen EF, Kassem M. Maintenance of osteoblastic and adipocytic differentiation potential with age and osteoporosis in human marrow stromal cell cultures. Calcif. Tissue Int. 71(1), 36–44 (2002).
   PubMed Web of Science ®Google Scholar
• Rosen ED, Spiegelman BM. Molecular regulation of adipogenesis. Annu. Rev. Cell Dev. Biol. 16, 145–71 (2000).
   PubMed Web of Science ®Google Scholar
• Tontonoz P, Graves RA, Budavari AI et al. Adipocyte-specific transcription factor ARF6 is a heterodimeric complex of two nuclear hormone receptors, PPAR γ and RXR α. Nucleic Acids Res. 22(25), 5628–5634 (1994).
   PubMed Web of Science ®Google Scholar
• MacDougald OA, Lane MD. Transcriptional regulation of gene expression during adipocyte differentiation. Annu. Rev. Biochem. 64, 345–373 (1995).
   PubMed Web of Science ®Google Scholar
• Tanaka T, Yoshida N, Kishimoto T, Akira S. Defective adipocyte differentiation in mice lacking the C/EBPβ and/or C/EBPδ gene. EMBO J. 16(24), 7432–7443 (1997).
   PubMed Web of Science ®Google Scholar
• Wu Z, Bucher NL, Farmer SR. Induction of peroxisome proliferator-activated receptor γ during the conversion of 3T3 fibroblasts into adipocytes is mediated by C/EBPβ, C/EBPδ, and glucocorticoids. Mol. Cell. Biol. 16(8), 4128–4136 (1996).
   PubMed Web of Science ®Google Scholar
• Darlington GJ, Ross SE, MacDougald OA. The role of C/EBP genes in adipocyte differentiation. J. Biol. Chem. 273(46), 30057–30060 (1998).
   PubMed Web of Science ®Google Scholar
• Rosen ED, Hsu CH, Wang X et al. C/EBPα induces adipogenesis through PPARγ: a unified pathway. Genes Dev. 16(1), 22–26 (2002).
   PubMed Web of Science ®Google Scholar
• Wu Z, Rosen ED, Brun R et al. Cross-regulation of C/EBP α and PPAR γ controls the transcriptional pathway of adipogenesis and insulin sensitivity. Mol. Cell. 3(2), 151–158 (1999).
   PubMed Web of Science ®Google Scholar
• Kim JB, Spiegelman BM. ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism. Genes Dev. 10(9), 1096–1107 (1996).
   PubMed Web of Science ®Google Scholar
• Kim JB, Wright HM, Wright M, Spiegelman BM. ADD1/SREBP1 activates PPARγ through the production of endogenous ligand. Proc. Natl Acad. Sci. USA 95(8), 4333–4337 (1998).
   PubMed Web of Science ®Google Scholar
• Spiegelman BM, Choy L, Hotamisligil GS, Graves RA, Tontonoz P. Regulation of adipocyte gene expression in differentiation and syndromes of obesity/diabetes. J. Biol. Chem. 268(10), 6823–6826 (1993).
   PubMed Web of Science ®Google Scholar
• Argmann CA, Cock TA, Auwerx J. Peroxisome proliferator-activated receptor γ: the more the merrier? Eur. J. Clin. Invest. 35(2), 82–92; discussion 80 (2005).
   PubMed Web of Science ®Google Scholar
• Akune T, Ohba S, Kamekura S et al. PPARγ insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J. Clin. Invest. 113(6), 846–855 (2004).
   PubMed Web of Science ®Google Scholar
• Madsen L, Petersen RK, Kristiansen K. Regulation of adipocyte differentiation and function by polyunsaturated fatty acids. Biochim. Biophys. Acta 1740(2), 266–286 (2005).
   PubMed Web of Science ®Google Scholar
• Krey G, Braissant O, L’Horset F et al. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol. Endocrinol. 11(6), 779–791 (1997).
   PubMed Web of Science ®Google Scholar
• Kliewer SA, Sundseth SS, Jones SA et al. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ. Proc. Natl Acad. Sci. USA 94(9), 4318–4323 (1997).
   PubMed Web of Science ®Google Scholar
• Klein RF, Allard J, Avnur Z et al. Regulation of bone mass in mice by the lipoxygenase gene Alox15. Science 303(5655), 229–232 (2004).
   PubMed Web of Science ®Google Scholar
• Nawrocki AR, Scherer PE. Keynote review: the adipocyte as a drug discovery target. Drug Discov. Today 10(18), 1219–1230 (2005).
   PubMed Web of Science ®Google Scholar
• Phillips JE, Gersbach CA, Wojtowicz AM, Garcia AJ. Glucocorticoid-induced osteogenesis is negatively regulated by Runx2/Cbfa1 serine phosphorylation. J. Cell Sci. 119(Pt 3), 581–591 (2006).
   PubMed Web of Science ®Google Scholar
• Eijken M, Koedam M, van Driel M, Buurman CJ, Pols HA, van Leeuwen JP. The essential role of glucocorticoids for proper human osteoblast differentiation and matrix mineralization. Mol. Cell. Endocrinol. 248(1–2), 87–93 (2006).
   PubMed Web of Science ®Google Scholar
• Wang FS, Lin CL, Chen YJ et al. Secreted frizzled-related protein 1 modulates glucocorticoid attenuation of osteogenic activities and bone mass. Endocrinology 146(5), 2415–2423 (2005).
   PubMed Web of Science ®Google Scholar
• Gu G, Hentunen TA, Nars M, Harkonen PL, Vaananen HK. Estrogen protects primary osteocytes against glucocorticoid-induced apoptosis. Apoptosis 10(3), 583–595 (2005).
   PubMed Web of Science ®Google Scholar
• O’Brien CA, Jia D, Plotkin LI et al. Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength. Endocrinology 145(4), 1835–1841 (2004).
   PubMed Web of Science ®Google Scholar
• Seckl JR, Morton NM, Chapman KE, Walker BR. Glucocorticoids and 11β-hydroxysteroid dehydrogenase in adipose tissue. Recent Prog. Horm. Res. 59, 359–393 (2004).
   PubMedGoogle Scholar
• Masuzaki H, Paterson J, Shinyama H et al. A transgenic model of visceral obesity and the metabolic syndrome. Science 294(5549), 2166–2170 (2001).
   PubMed Web of Science ®Google Scholar
• Morton NM, Paterson JM, Masuzaki H et al. Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 β-hydroxysteroid dehydrogenase type 1-deficient mice. Diabetes 53(4), 931–938 (2004).
   PubMed Web of Science ®Google Scholar
• Price TM, O’Brien SN. Determination of estrogen receptor messenger ribonucleic acid (mRNA) and cytochrome P450 aromatase mRNA levels in adipocytes and adipose stromal cells by competitive polymerase chain reaction amplification. J. Clin. Endocrinol. Metab. 77(4), 1041–1045 (1993).
   PubMed Web of Science ®Google Scholar
• Cooke PS, Naaz A. Role of estrogens in adipocyte development and function. Exp. Biol. Med. (Maywood) 229(11), 1127–1135 (2004).
   PubMed Web of Science ®Google Scholar
• Heine PA, Taylor JA, Iwamoto GA, Lubahn DB, Cooke PS. Increased adipose tissue in male and female estrogen receptor-α knockout mice. Proc. Natl Acad. Sci. USA 97(23), 12729–12734 (2000).
   PubMed Web of Science ®Google Scholar
• Jones ME, Thorburn AW, Britt KL et al. Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc. Natl Acad. Sci. USA 97(23), 12735–12740 (2000).
   PubMed Web of Science ®Google Scholar
• Danilovich N, Babu PS, Xing W, Gerdes M, Krishnamurthy H, Sairam MR. Estrogen deficiency, obesity, and skeletal abnormalities in follicle-stimulating hormone receptor knockout (FORKO) female mice. Endocrinology 141(11), 4295–4308 (2000).
   PubMed Web of Science ®Google Scholar
• Girard J, Perdereau D, Foufelle F, Prip-Buus C, Ferre P. Regulation of lipogenic enzyme gene expression by nutrients and hormones. FASEB J. 8(1), 36–42 (1994).
   PubMed Web of Science ®Google Scholar
• Kiess W, Gallaher B. Hormonal control of programmed cell death/apoptosis. Eur. J. Endocrinol. 138(5), 482–491 (1998).
   PubMed Web of Science ®Google Scholar
• Tseng YH, Butte AJ, Kokkotou E et al. Prediction of preadipocyte differentiation by gene expression reveals role of insulin receptor substrates and necdin. Nat. Cell Biol. 7(6), 601–611 (2005).
   PubMed Web of Science ®Google Scholar
• Leri A, Kajstura J, Anversa P. Identity deception: not a crime for a stem cell. Physiology (Bethesda) 20, 162–168 (2005).
   PubMed Web of Science ®Google Scholar
• Terada N, Hamazaki T, Oka M et al. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 416(6880), 542–545 (2002).
   PubMed Web of Science ®Google Scholar
• Ying QL, Nichols J, Evans EP, Smith AG. Changing potency by spontaneous fusion. Nature 416(6880), 545–548 (2002).
   PubMed Web of Science ®Google Scholar
• Nuttall ME, Patton AJ, Olivera DL, Nadeau DP, Gowen M. Human trabecular bone cells are able to express both osteoblastic and adipocytic phenotype: implications for osteopenic disorders. J. Bone Miner. Res. 13(3), 371–382 (1998).
   PubMed Web of Science ®Google Scholar
• Bluher S, Kratzsch J, Kiess W. Insulin-like growth factor I, growth hormone and insulin in white adipose tissue. Best Pract. Res. Clin. Endocrinol. Metab. 19(4), 577–587 (2005).
   PubMed Web of Science ®Google Scholar
• Simonsen JL, Rosada C, Serakinci N et al. Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. Nat. Biotechnol. 20(6), 592–596 (2002).
   PubMed Web of Science ®Google Scholar
• Abdallah BM, Haack-Sorensen M, Burns JS et al. Maintenance of differentiation potential of human bone marrow mesenchymal stem cells immortalized by human telomerase reverse transcriptase gene despite [corrected] extensive proliferation. Biochem. Biophys. Res. Commun. 326(3), 527–538 (2005).
   PubMed Web of Science ®Google Scholar
• Kipling D, Davis T, Ostler EL, Faragher RG. What can progeroid syndromes tell us about human aging? Science 305(5689), 1426–1431 (2004).
   PubMed Web of Science ®Google Scholar
• Sethe S, Scutt A, Stolzing A. Aging of mesenchymal stem cells. Aging Res. Rev. 5(1), 91–116 (2006).
   PubMed Web of Science ®Google Scholar
• Ebert R, Ulmer M, Zeck S et al. Selenium supplementation restores the antioxidative capacity and prevents cell damage in bone marrow stromal cells in vitro. Stem Cells 24(5), 1226–1235 (2006).
   PubMed Web of Science ®Google Scholar
• Schutze N, Fritsche J, Ebert-Dumig R et al. The selenoprotein thioredoxin reductase is expressed in peripheral blood monocytes and THP1 human myeloid leukemia cells – regulation by 1,25-dihydroxyvitamin D3 and selenite. Biofactors 10(4), 329–338 (1999).
   PubMed Web of Science ®Google Scholar
• Damdimopoulos AE, Miranda-Vizuete A, Treuter E, Gustafsson JA, Spyrou G. An alternative splicing variant of the selenoprotein thioredoxin reductase is a modulator of estrogen signaling. J. Biol. Chem. 279(37), 38721–38729 (2004).
   PubMed Web of Science ®Google Scholar
• Maruyama T, Sachi Y, Furuke K et al. Induction of thioredoxin, a redox-active protein, by ovarian steroid hormones during growth and differentiation of endometrial stromal cells in vitro. Endocrinology 140(1), 365–372 (1999).
   PubMed Web of Science ®Google Scholar
• Stenderup K, Justesen J, Eriksen EF, Rattan SI, Kassem M. Number and proliferative capacity of osteogenic stem cells are maintained during aging and in patients with osteoporosis. J. Bone Miner. Res. 16(6), 1120–1129 (2001).
   PubMed Web of Science ®Google Scholar
• Roura S, Farre J, Soler-Botija C et al. Effect of aging on the pluripotential capacity of human CD105+ mesenchymal stem cells. Eur. J. Heart Fail. 8(6), 555–563 (2006).
   PubMed Web of Science ®Google Scholar
• Dressler MR, Butler DL, Boivin GP. Effects of age on the repair ability of mesenchymal stem cells in rabbit tendon. J. Orthop. Res. 23(2), 287–293 (2005).
   PubMed Web of Science ®Google Scholar
• Stenderup K, Justesen J, Clausen C, Kassem M. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 33(6), 919–926 (2003).
   PubMed Web of Science ®Google Scholar
• Park JS, Kim HY, Kim HW et al. Increased caveolin-1, a cause for the declined adipogenic potential of senescent human mesenchymal stem cells. Mech. Aging Dev. 126(5), 551–559 (2005).
   PubMed Web of Science ®Google Scholar
• Abdallah BM, Haack-Sorensen M, Fink T, Kassem M. Inhibition of osteoblast differentiation but not adipocyte differentiation of mesenchymal stem cells by sera obtained from aged females. Bone (2006).
   PubMed Web of Science ®Google Scholar
• Dazzi F, Ramasamy R, Glennie S, Jones SP, Roberts I. The role of mesenchymal stem cells in haemopoiesis. Blood Rev. 20(3), 161–171 (2006).
   PubMed Web of Science ®Google Scholar
• Morrison SJ, Kimble J. Asymmetric and symmetric stem-cell divisions in development and cancer. Nature 441(7097), 1068–1074 (2006).
   PubMed Web of Science ®Google Scholar
• Bogazzi F, Cosci C, Sardella C, Martino E, Gasperi M. Acromegaly: effects on bone metabolism and mass. J. Endocrinol. Invest. 28(Suppl. 10), 33–35 (2005).
   PubMedGoogle Scholar
• Lombardi G, Tauchmanova L, Di Somma C et al. Somatopause: dismetabolic and bone effects. J. Endocrinol. Invest. 28(Suppl. 10), 36–42 (2005).
   PubMedGoogle Scholar
• Liang H, Masoro EJ, Nelson JF, Strong R, McMahan CA, Richardson A. Genetic mouse models of extended lifespan. Exp. Gerontol. 38(11–12), 1353–1364 (2003).
   PubMed Web of Science ®Google Scholar
• Bonjour JP. Dietary protein: an essential nutrient for bone health. J. Am. Coll. Nutr. 24(Suppl. 6), S526–S536 (2005).
   PubMed Web of Science ®Google Scholar
• Legroux-Gerot I, Vignau J, Collier F, Cortet B. Bone loss associated with anorexia nervosa. Joint Bone Spine 72(6), 489–495 (2005).
   PubMed Web of Science ®Google Scholar
• Chanoine JP. Ghrelin in growth and development. Horm. Res. 63(3), 129–138 (2005).
   PubMedGoogle Scholar
• Oreffo RO, Lashbrooke B, Roach HI, Clarke NM, Cooper C. Maternal protein deficiency affects mesenchymal stem cell activity in the developing offspring. Bone 33(1), 100–107 (2003).
   PubMed Web of Science ®Google Scholar
• Smith EP, Boyd J, Frank GR et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N. Engl. J. Med. 331(16), 1056–1061 (1994).
   PubMed Web of Science ®Google Scholar
• Morishima A, Grumbach MM, Simpson ER, Fisher C, Qin K. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J. Clin. Endocrinol. Metab. 80(12), 3689–3698 (1995).
   PubMed Web of Science ®Google Scholar
• Augat P, Simon U, Liedert A, Claes L. Mechanics and mechano-biology of fracture healing in normal and osteoporotic bone. Osteoporos Int. 16(Suppl. 2), S36–S43 (2005).
   PubMed Web of Science ®Google Scholar
• Namkung-Matthai H, Appleyard R, Jansen J et al. Osteoporosis influences the early period of fracture healing in a rat osteoporotic model. Bone 28(1), 80–86 (2001).
   PubMed Web of Science ®Google Scholar